genetic screening

Oncology

Functional cancer profiling is an important step forward in the progress of oncology treatment, with the potential to transform patient outcomes.

News

Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.